Clinical Trial 23894

• Overview

  Study Title:

  Smoking Cessation and Alcohol Use among Cancer Survivors: Investigating the Efficacy of a Mindfulness- Based Intervention

  Summary:

  The purpose of this study is to obtain feedback on a mindfulness-based intervention for smoking and alcohol among cancer survivors.

  Objective:

  Aim 1: Pilot Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) to ensure acceptability among cancer survivors who want to quit smoking and modify their alcohol use. Aim 2: Test the efficacy of MBRP-SA as compared to QL among cancer survivors and explore potential moderators, mechanisms, and predictors of treatment effects. Aim 3: Evaluate treatment implementation outcomes to guide future MBRP-SA adoption.

• Inclusion Criteria

  Inclusion Criteria:
  • 18 years of age or older
  • History of a cancer diagnosis at any point in lifetime
  • Smoked >/=cigarette/day in past month
  • At least one binge drinking episode in past month or exceeds weekly drinking limits
  • Motivated to quit smoking and modify alcohol use in next 30 days
  • Valid home address in Florida
  • English‑speaking, reading, and writing ability

• Exclusion Criteria

  Exclusion Criteria:
  • Pregnancy or lactation
  • Active psychotic disorder
  • History of severe alcohol withdrawal
  • Current use of tobacco cessation medication or other treatments to quit smoking
  • End-of‑life or hospice care
  • Household member already enrolled

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.